Physiologic Ocular Changes During Pregnancy in Women With High Myopia.
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The prevalence of myopia is seemingly increasing, and it is one of the major causes of blindness. High myopia is defined as a refractive error with spherical equivalent exceeding -6 diopters and/or the axial length longer than 26.5 mm. The global prevalence of high myopia is estimated to rise from 2.7% of the world population in 2010 to 9.8% of the world population in 2050. High myopia is characterized by axial length elongation, and consequent stretching of the posterior eye wall (thin retina and choroid). There are many complications of high myopia such as posterior staphyloma, lacquer cracks and myopic choroidal neovascularization. Normal labour may cause the ocular complication in pregnant women with high myopia, such as macular hemorrhage. Therefore, the caesarean section with epidural anesthesia is recommended. Moreover, there is no standard screening guideline for pregnant women with high myopia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJune 30, 2021
June 1, 2021
3.5 years
February 25, 2021
June 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Choroidal thickness
Choroidal thickness was measured by optical coherence tomography
40 weeks
Secondary Outcomes (4)
Retinal vascular density
40 weeks
Retinal nerve fiber layer thickness
40 weeks
Corneal thickness
40 weeks
Corneal curvature
40 weeks
Study Arms (1)
Normal pregnant women with high myopia
EXPERIMENTALCorneal topography, Optical coherence tomography (OCT) and Optical coherence tomography angiography (OCTA) were performed in each trimesters and at 6 weeks after childbirth.
Interventions
Ocular investigations were performed in each trimesters and at 6 weeks after childbirth. 1. st trimester : gestational age 8-12 weeks 2. nd trimester : gestational age 24-28 weeks 3. rd trimester : gestational age 34-38 weeks
Eligibility Criteria
You may qualify if:
- age \> 18 years
- high myopia: spherical equivalent \> 6 diopters and/or axial length \> 26.5 mm
- singleton pregnancy
- clear ocular media
- written inform consent
You may not qualify if:
- high risk pregnancy such as pre-eclampsia, gestational diabetes mellitus, hyperthyroidism and asthma.
- history of retinal diseases such as macular edema and retinal vascular occlusion
- history of intraocular inflammation or endophthalmitis
- history of intraocular laser treatment
- history of intraocular surgery
- Withdrawal criteria
- childbirth before 34 weeks' gestation
- multifetal pregnancy was detected by ultrasound
- high risk pregnancy which could not follow the research protocol such as severe pre-eclampsia
- retinal diseases occur during the follow-up period such as central serous chorioretinopathy, retinal detachment and choroidal neovascularization
- significant ocular trauma during the follow-up period
- severe peripartum or postpartum complications such as thromboembolic disease and postpartum hemorrhage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suthasinee Sinawat, MD
KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 25, 2021
First Posted
February 26, 2021
Study Start
July 1, 2021
Primary Completion
December 30, 2024
Study Completion
June 30, 2025
Last Updated
June 30, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share